Amarin Corp Plc (AMRN)

[rogerm]

ESC Conf starts Aug 30th-EPA Abstracts

Pre-treatment with pure eicosapentaenoic acid in addition to statins can reduce the index of microcirculatory resistance after percutaneous coronary intervention Akiyoshi KURITA (Nagakute, JP)

Effect of pitavastatin and eicosapentaenoic acid on coronary artery calcification detected by multi detector-row computed tomography. Kazufumi NAKAMURA (Okayama, JP)

Eicosapentaenoic acid treatment reduces acute inflammatory response and ventricular arrhythmias in patients with reperfused acute myocardial infarction Saori TSUKUDA (Takamatsu City, JP)

Clinical outcomes of early initiation of pure eicosapentaenoic acid supplement after percutaneous coronary intervention in patients with acute coronary syndrome. Fumi YOKOHAMA (Takamatsu, JP)

Association between plaque vulnerability and eicosapentaenoic acid to arachidonic acid in non-hypercholesterolemia patients Maoto HABARA (Toyohashi, JP)

Combined administration of eicosapentaenoic acid and docosahexaenoic acid reduces atherosclerotic lesion in apolipoprotein E-deficient mice Akira TAKASHIMA (Tokushima, JP)

Eicosapentaenoic acid to arachidonic acid ratio is associated with the presence of thin-cap fibroatheroma determined by optical coherence tomography Yasushi WAKABAYASHI (Saitama, JP)

Inhibitory effects of eicosapentaenoic acid on arterial calcification in klotho mutant mice, an animal model of typical aging Kazufumi NAKAMURA (Okayama, JP)

http://spo.escardio.org/default.aspx?eevtid=69